PTPA and prostate carcinoma: PLK1 was over-expressed in many cancers, including prostate cancer, and scientists found that translation of the PP2A-PLK1 SDL interaction caused the expression of PLK1 and PP2A, which were commonly regarded as a biomarker in the cancer cells [29].